Sharma Prabhakar

Dr. Sharma Prabhakar


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2007 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
SPSharma Prabhakar
Sharma Prabhakar
JSJoel Starnes
Joel Starnes
SSShuping Shi
Shuping Shi
BLBetty Lonis
Betty Lonis
RTRuc Tran
Ruc Tran
The pathogenesis of diabetic nephropathy remains far from clear, partly due to the lack of a suitable animal model that mimics human renal disease in type 2 diabetes. In this study, the natural history of renal manifestations in ZSF1 rats, a recently developed rodent model of type 2 diabetes, is described. Male ZSF1 rats developed obesity and hyperglycemia by 20 weeks of age on a high-carbohydrate diet. They also developed systolic and diastolic hypertension, hypercholesterolemia, profound hypertriglyceridemia, proteinuria, and renal failure. Renal histology demonstrated changes consistent with early diabetic nephropathy, including arteriolar thickening, tubular dilation and atrophy, glomerular basement membrane thickening, and mesangial expansion. Furthermore, renal nitric oxide production was decreased, and homogenates from renal cortices demonstrated reduced expression of renal endothelial and inducible nitric oxide synthases. These changes were associated with increased urinary levels and renal expression of 8-hydroxydeoxyguanosine, an indicator of mitochondrial oxidative stress, as well as with increased renal peroxynitrite formation. Administration of either insulin or the antioxidant alpha-lipoic acid decreased proteinuria and oxidative stress, but only the former slowed progression of renal failure. We conclude that ZSF1 rats represent the best available rat model to study nephropathy from type 2 diabetes and that the renal lesions are associated with increased oxidative stress and decreased renal nitric oxide availability.

1 July 2004 in Seminars in Nephrology
Verified
Journal Article
Closed access
SPSharma Prabhakar
Sharma Prabhakar

1 December 2012 in Journal of Investigative Medicine
Verified
Journal Article
Closed access
SPSharma Prabhakar
Sharma Prabhakar
Translation of scientific discoveries into meaningful human applications, particularly novel therapies of human diseases, requires development of suitable animal models. Experimental approaches to test new drugs in preclinical phases often necessitated animal models that not only replicate human disease in etiopathogenesis and pathobiology but also biomarkers development and toxicity prediction. Whereas the transgenic and knockout techniques have revolutionized manipulation of rodents and other species to get greater insights into human disease pathogenesis, we are far from generating ideal animal models of most human disease states. The challenges in using the currently available animal models for translational research, particularly for developing potentially new drugs for human disease, coupled with the difficulties in toxicity prediction have led some researchers to develop a scoring system for translatability. These aspects and the challenges in selecting an animal model among those that are available to study human disease pathobiology and drug development are the topics covered in this detailed review.

1 November 2006 in Current Diabetes Reports
Verified
Journal Article
Closed access
PDF file
RRRey F. Rosario
Rey F. Rosario
SPSharma Prabhakar
Sharma Prabhakar

13 April 2012 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
JHJennifer A Hobin
Jennifer A Hobin
ADAnne M Deschamps
Anne M Deschamps
RBRichard Bockman
Richard Bockman
SCStanley Cohen
Stanley Cohen
PDPaul Dechow
Paul Dechow
RGRichard Galbraith
Richard Galbraith
This report is based on the Federation of American Societies for Experimental Biology’s symposium, “Engaging basic Scientists in Translational Research: Identifying Opportunities, Overcoming Obstacles,” held in Chevy Chase, MD, March 24–25, 2011. Meeting participants examined the benefits of engaging basic scientists in translational research, the challenges to their participation in translational research, and the roles that research institutions, funding organizations, professional societies, and scientific publishers can play to address these challenges.

1 January 2017
Verified
Book Chapter
Closed access
HSH. Sobamowo
H. Sobamowo
SPSharma Prabhakar
Sharma Prabhakar